FendXLogo-GreenBG-1200w

DIRECTORS

Board of Directors

Dr. Carolyn Myers, MBA, PhD

President, Chief Executive Officer, Director

Dr. Carolyn Myers

Dr. Carolyn Myers MBA, PhD
President, Chief Executive Officer and Director 

Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading healthcare businesses. Dr. Myers is currently CEO of FendX Technologies Inc. She is also a Principal of BioEnsemble LLC, where she works closely with numerous start-ups and small pharma companies to assist them in developing their business strategy and planning. Her previous executive positions include Vice President International Business Development and Alliance Management at Allergan PLC, President of Dey Laboratories and President of Mylan Technologies Inc. Prior to serving in these roles, Dr. Myers served in various management positions in sales and marketing at Pharmacia Corporation., now a part of Pfizer, Inc. Dr. Myers is also a director Mayne Pharma Group Ltd. and Hyloris Pharmaceuticals SA, both publicly listed companies. She earned her PhD in genetics from the University of British Columbia and her MBA from Rutgers University.

STEPHEN RANDALL

Independent Board Member & Audit Committee Chair

Dr. Carolyn Myers

Stephen Randall CPA, CGA 
Independent Board Member and Audit Committee Chair

Stephen Randall is an experienced senior financial manager and Director with over 40 years’ experience.  Mr. Randall has served in senior financial roles with both private, publicly traded and start-up companies in the manufacturing, telecommunications, technology, and medical device sectors. From 2010 until 2020, Mr. Randall was the CFO and Corporate Secretary of Titan Medical Inc., a Canadian medical device development company listed on both the TSX, (TMD) and Nasdaq, (TMDI). For the years 2017 to 2021 he was also on the Board of Directors of Titan Medical Inc. Previous Board experience includes Community Head Injury Resource Services (CHIRS) from 2010 to 2016 where he served as a Director, Treasurer and Chair of the Audit Committee. Mr. Randall holds the Canadian CPA, CGA designation as well as a Hon. B. Comm. and B.A.

PIERRE SOULARD, B.C.L., LLB, LLM​

Independent Board Member​

Dr. Carolyn Myers

Pierre Soulard B.C.L., LLB, LLM
Independent Board Member

Pierre Soulard is the Chief Legal Officer of CoinSmart (NEO: SMRT) and is a former partner, at Miller Thomson, a leading Canadian law firm. Mr. Soulard’s legal practice focused on securities law, corporate finance, mergers and acquisitions and corporate governance for a wide range of national and international issuers and investors. Mr. Soulard obtained a Bachelor of Arts from Laval University, a B.C.L./LLB from McGill University and a Master of Law from Osgoode Hall Law School.

FendX Technologies Inc. (CSE: FNDX | OTCQB: FDXTF | FSE: E8D) – Innovative nanotechnology that reduces the spread of viruses and bacteria.

Quick contact
  • 2010 Winston Park Drive
    2nd Floor
    Oakville, Ontario, Canada
    L6H 5R7
    1-800-344-9868
  • info@fendxtech.com
The company
Follow us
Facebook Linkedin

REPELWRAP is a trademark of FendX Technologies Inc., 2023